Institution

Bluebird Bio

Biography

Involved in the bluebird bio Lentiglobin program for patients affected by hemoglobinopathies, as Subinvestigator-Coordinator of the proof of concept study HGB-205 between 2010 to 2017 and then in charge of the Clinical trials for Sickle Cell Disease as Associated Medical Director at bluebird bio Cambridge (MA) USA since September 2017.
Clinical Hematology attending specialized in Red Cell Disorders, and Clinical Research and Scientific activities at Necker University Hospital 2001-2017.